Moein Moghimi is a Professor of Pharmaceutics and Nanomedicine (School of Pharmacy) and Research Professor at the Translational and Clinical Research Institute at Newcastle University (UK); adjoint Professor at the Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado-Denver Medical Center (CO, USA); and Deputy Editor of Molecular Therapy. Professor Moghimi is co-founder of S. M. Discovery Group Inc. (Colorado, USA) and S. M. Discovery Group Ltd. (UK). His earlier appointments have included Professor and Chair in Pharmaceutics at the School of Medicine, Pharmacy and Health, Durham University (UK) from 2016–2017; Full Affiliate Member/Professor at the Methodist Research Institute, Houston Methodist Hospital Systems (TX, USA) from 2013–2017; visiting Professor at Università Degli Studi Di Padova, (Italy) in 2015; Professor of Nanomedicine (at the Department of Pharmacy), Professor of Pharmaceutical Nanotechnology at the Nanoscience Center (Cambridge, UK), and Founder/Director of the multi-million dollar Center for Pharmaceutical Nanotechnology and Nanotoxiocology, University of Copenhagen (Denmark) (2008–2016) and Honorary Professor of Nanomedicine at the Multidisciplinary Research Center, Shantou University in China (2008–2010).
Prof. Moghimi’s research is centered on fundamental and translational aspects of nanomedicine engineering and performance, with the overall goal of advancing fundamental understanding of biological barriers, particularly the role of the innate immune system, in relation to nanoparticle performance and safety, and within the context of precision medicine applicable to cancer, cardiovascular diseases, immune disorders and disease of the central nervous system. As of January 2020, Prof. Moghimi has over 280 peer-reviewed publications/patents in the field and has given over 400 invited talks, keynotes and plenaries.
Alma Mater (Biochemistry): University of Manchester, UK
PhD (Biochemistry): Charing Cross and Westminster Medical School, University of London (Imperial College), UK